Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Luca Pinello, Ph.D.

Co-Author

This page shows the publications co-authored by Luca Pinello and Kendell Clement.
Connection Strength

3.542
  1. Technologies and Computational Analysis Strategies for CRISPR Applications. Mol Cell. 2020 07 02; 79(1):11-29.
    View in: PubMed
    Score: 0.882
  2. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol. 2019 03; 37(3):224-226.
    View in: PubMed
    Score: 0.804
  3. AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics. 2018 07 01; 34(13):i202-i210.
    View in: PubMed
    Score: 0.768
  4. Assessment of computational methods for the analysis of single-cell ATAC-seq data. Genome Biol. 2019 11 18; 20(1):241.
    View in: PubMed
    Score: 0.211
  5. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data. Nat Methods. 2018 12; 15(12):992-993.
    View in: PubMed
    Score: 0.198
  6. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo". Nat Methods. 2018 04; 15(4):238-239.
    View in: PubMed
    Score: 0.189
  7. Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat Biotechnol. 2022 Feb; 40(2):273.
    View in: PubMed
    Score: 0.062
  8. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat Biotechnol. 2022 Feb; 40(2):189-193.
    View in: PubMed
    Score: 0.058
  9. A Code of Ethics for Gene Drive Research. CRISPR J. 2021 02; 4(1):19-24.
    View in: PubMed
    Score: 0.058
  10. High throughput single-cell detection of multiplex CRISPR-edited gene modifications. Genome Biol. 2020 10 20; 21(1):266.
    View in: PubMed
    Score: 0.056
  11. Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2020 Jul; 38(7):901.
    View in: PubMed
    Score: 0.055
  12. Therapeutic base editing of human hematopoietic stem cells. Nat Med. 2020 04; 26(4):535-541.
    View in: PubMed
    Score: 0.054
  13. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med. 2019 05; 25(5):776-783.
    View in: PubMed
    Score: 0.050
  14. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2019 03; 37(3):276-282.
    View in: PubMed
    Score: 0.050
  15. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature. 2018 09; 561(7723):416-419.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.